BackBonus BioGroup Overview

Bonus BioGroup Current Cash

Bonus BioGroup's current cash is $440K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$439000.00
↓ 63.32% YoYΔ $-758000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Bonus BioGroup Current Cash History

Loading

Bonus BioGroup vs. peers: Current Cash Comparison

Loading

Bonus BioGroup Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bonus BioGroup (BONS.TA) FAQ

Bonus BioGroup's current cash stands at $440K as of June 2026. That compares with $1.2M in the prior-year period — down 63.3% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Bonus BioGroup reported $440K in current cash versus $1.2M a year earlier — a 63.3% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $1.2M in the prior-year period — down 63.3% year over year. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Bonus BioGroup's current cash evolved across reporting periods, while the comparison chart places BONS.TA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current cash is commonly used to spot outliers. Bonus BioGroup's reading of $440K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.